Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Y Chih

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Blood|October 24, 1997
Modulation of mRNA expression of a novel human myeloid-selective CCAAT/enhancer binding protein gene (C/EBP epsilon)D Y Chih, A M Chumakov, D J Park, et al.
Blood|November 23, 2000
Representational difference analysis using myeloid cells from C/EBP epsilon deletional miceT Kubota, S Kawano, D Y Chih, et al.
Leukemia Research|October 13, 2001
DNase I hypersensitivity analysis of the human CCAAT enhancer binding protein epsilon (C/EBPepsilon) geneT Kubota, T Hirama, W Verbeek, et al.
The Journal of Clinical Investigation|May 20, 1999
CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatmentD J Park, A M Chumakov, P T Vuong, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Blood|October 24, 1997
Modulation of mRNA expression of a novel human myeloid-selective CCAAT/enhancer binding protein gene (C/EBP epsilon)D Y Chih, A M Chumakov, D J Park, et al.
Blood|November 23, 2000
Representational difference analysis using myeloid cells from C/EBP epsilon deletional miceT Kubota, S Kawano, D Y Chih, et al.
Leukemia Research|October 13, 2001
DNase I hypersensitivity analysis of the human CCAAT enhancer binding protein epsilon (C/EBPepsilon) geneT Kubota, T Hirama, W Verbeek, et al.
The Journal of Clinical Investigation|May 20, 1999
CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatmentD J Park, A M Chumakov, P T Vuong, et al.
Pageof 1